Pharma News India

The Indian firm has spent 27.4 million euro so far in a bid to acquire OctoPlus.

Hyderabad, February 12, 2013: Dr Reddy's Laboratories (DRL) has so far managed to get nearly 93 per cent shares of OctoPlus NV in its favour by spending 27.4 million euro.


The manufacturing unit is expected to attract an investment of 20 million euros.

Ahmedabad, February 8, 2013: The Indo-German joint venture between Schott AG and Kaisha Manufacturers Pvt Ltd, Schott Kaisha, is setting up an automated plant for pharmaceutical packaging in Jambusar, Gujarat, with an investment of 20 million euros.


The European unit of the company has launched its first product in Britain.

New Delhi, February 7, 2013: Glenmark Pharmaceuticals Ltd has announced that the European unit of the company has launched the generic version of GlaxoSmithKline's Malarone malaria treatment medicine. It is worth mentioning here that it is the first product from the company in Britain.


The approval is to market generic version of Doxil injection, used in treating ovarian cancer in the US.

New Delhi, February 6, 2013: The Indian pharma company, Sun Pharma, has received the approval from the US health regulator, US Food and Drug Administration (USFDA) to market generic version of Doxil injection, used in treating ovarian cancer in the US. The Mumbai-based firm sai...


Top Indian pharma companies are expected to grow at 20 per cent in 2013.

Mumbai, February 3, 2013: As per a recently released report from India Ratings, top Indian pharma players will continue to grow strongly at over 20 per cent in 2013, primarily because of the exports to the US market. "Of the export markets, Indian pharma will focus on the US market which presents significant ...


Comment!

 
 






* Indicates mandatory field.
Please wait while comments are being sent...